Advisors Asset Management Inc. Sells 6,983 Shares of Henry Schein, Inc. (HSIC)

Advisors Asset Management Inc. trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 33.7% during the second quarter, HoldingsChannel reports. The firm owned 13,757 shares of the company’s stock after selling 6,983 shares during the period. Advisors Asset Management Inc.’s holdings in Henry Schein were worth $999,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in HSIC. FMR LLC boosted its stake in shares of Henry Schein by 167.3% during the second quarter. FMR LLC now owns 6,632,783 shares of the company’s stock valued at $481,805,000 after purchasing an additional 4,151,179 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Henry Schein by 2,573.5% during the second quarter. Point72 Asset Management L.P. now owns 802,047 shares of the company’s stock valued at $58,261,000 after purchasing an additional 772,047 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Henry Schein by 21.2% during the second quarter. American Century Companies Inc. now owns 2,191,660 shares of the company’s stock valued at $159,202,000 after purchasing an additional 383,479 shares in the last quarter. Glenmede Trust Co. NA boosted its stake in shares of Henry Schein by 11,084.6% during the second quarter. Glenmede Trust Co. NA now owns 355,000 shares of the company’s stock valued at $25,787,000 after purchasing an additional 351,826 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of Henry Schein by 7.1% during the second quarter. Janus Henderson Group PLC now owns 3,180,363 shares of the company’s stock valued at $231,022,000 after purchasing an additional 209,562 shares in the last quarter.

A number of analysts have recently commented on HSIC shares. BidaskClub raised Henry Schein from a “hold” rating to a “buy” rating in a research note on Wednesday, August 22nd. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $85.00 price target on the stock in a research note on Tuesday, July 10th. Leerink Swann set a $100.00 price target on Henry Schein and gave the company a “buy” rating in a research note on Tuesday, August 7th. Barrington Research reissued a “buy” rating and set a $92.00 price target on shares of Henry Schein in a research note on Tuesday, August 7th. Finally, Craig Hallum lifted their price target on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, August 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average price target of $83.53.

Henry Schein stock opened at $83.51 on Friday. The company has a current ratio of 1.29, a quick ratio of 0.68 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $12.79 billion, a P/E ratio of 21.80, a P/E/G ratio of 2.55 and a beta of 0.87. Henry Schein, Inc. has a one year low of $62.56 and a one year high of $90.52.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, August 6th. The company reported $1.04 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.03. The company had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.88 earnings per share. Equities analysts predict that Henry Schein, Inc. will post 4.12 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Story: How does inflation affect different investments?

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply